Welcome to our dedicated page for Lumexa Imaging Holdings SEC filings (Ticker: LMRI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lumexa Imaging Holdings, Inc. filings document the public-company record for a Nasdaq-listed outpatient medical imaging provider. The company’s disclosures cover its common stock, completed initial public offering, registration statement history, stockholder agreements and capital-structure matters.
LMRI regulatory filings include definitive proxy materials for annual meeting votes and governance matters, Form 8-K reports on financial results, Regulation FD updates, executive transition and compensation arrangements, and material financing agreements. Debt-related filings describe the company’s senior secured credit facility, revolving credit arrangements, maturity terms, interest-rate framework and restrictive covenants affecting operating subsidiaries.
Lumexa Imaging Holdings, Inc. has amended its main debt facilities through an updated credit agreement for its subsidiaries. The new structure includes a secured term loan of approximately $823 million, called the Replacement Term Loan, and a secured revolving credit facility of $250 million.
Both facilities bear interest at the borrowers’ option at SOFR plus 2.50% or the Prime Rate plus 1.50%. The Replacement Term Loan matures in December 2032, while the Amended Revolving Credit Facility matures in December 2030, extending the company’s debt maturity profile.
The agreement imposes restrictive covenants on subsidiary actions such as incurring additional debt and paying dividends, and introduces a financial covenant if revolving exposure exceeds 40% of the revolver’s principal. In that case, Lumexa’s consolidated net leverage ratio must not exceed 7.50 to 1, with standard lender remedies available after an event of default.
Mittl Robert Louis Jr. reported acquisition or exercise transactions in this Form 4 filing.
Lumexa Imaging Holdings, Inc. director Robert Louis Mittl Jr. received an equity award in the form of restricted stock units. He was granted 19,358 RSUs, each representing the right to receive one share of Lumexa common stock.
The RSUs vest on the earlier of the one-year anniversary of the grant date or the next annual meeting of Lumexa’s stockholders, as long as he continues serving the company. Following this award, he holds 19,358 shares/units directly, reflecting compensation rather than an open-market share purchase or sale.
Lungren Matthew reported acquisition or exercise transactions in this Form 4 filing.
Lumexa Imaging Holdings, Inc. reported that director Matthew Lungren received a grant of 19,358 restricted stock units (RSUs) of common stock. The award was recorded at a price of $0.00 per share because it is a stock-based compensation grant, not an open-market purchase.
The RSUs represent the right to receive an equal number of common shares and will vest on the earlier of one year from the grant date or the next annual stockholder meeting, as long as Lungren continues serving the company. After this grant, he directly holds 19,358 common shares tied to this award.
Karlin Bridget E reported acquisition or exercise transactions in this Form 4 filing.
Lumexa Imaging Holdings, Inc. director Bridget E. Karlin received an equity grant of 19,358 restricted stock units (RSUs), each representing one share of common stock. The award was granted at no cash cost per unit and is a form of stock-based compensation rather than an open-market purchase.
The RSUs will vest on the earlier of one year from the grant date or the next annual stockholder meeting, provided she continues serving the company. Following this grant, her reported direct holding related to this award is 19,358 shares/RSUs, aligning her compensation more closely with shareholder value.
Lumexa Imaging Holdings, Inc. director Joseph Molly reported an equity compensation grant. He acquired 19,358 shares of common stock at a price of $0.00 per share as a grant or award, increasing his direct holdings to 46,385 shares.
The award is structured as restricted stock units, each representing the right to receive one share of common stock. These RSUs vest on the earlier of the one-year anniversary of the grant date or the next annual meeting of stockholders, as long as Molly continues to serve the company.
EISENBERG GLENN A reported acquisition or exercise transactions in this Form 4 filing.
Lumexa Imaging Holdings, Inc. director Glenn A. Eisenberg received an equity compensation grant of 19,358 restricted stock units (RSUs) of common stock on June 10, 2026. Each RSU represents the right to receive one share of common stock if vesting conditions are met.
The RSUs will vest on the earlier of the one-year anniversary of the grant date and the next annual meeting of Lumexa Imaging’s stockholders, subject to Eisenberg’s continued service with the company. Following this award, he holds 19,358 shares/RSUs directly according to the filing.
Cooper Henry Lee reported acquisition or exercise transactions in this Form 4 filing.
Lumexa Imaging Holdings director Cooper Henry Lee reported a compensation-related equity grant and his indirect holdings. He received 19,358 shares of common stock as restricted stock units at $0.00 per share, which vest on the earlier of one year from grant or the next annual stockholder meeting, subject to continued service. Following this grant, he holds 19,358 shares directly and 30,000 shares indirectly through the Cooper Family Trust, where he and his spouse are co-trustees, with beneficial ownership of the trust shares disclaimed except for his pecuniary interest.
BRODNAX BRETT reported acquisition or exercise transactions in this Form 4 filing.
Lumexa Imaging Holdings director Brett Brodnax received a grant of 19,358 restricted stock units (RSUs) of common stock. The award was made at no cash cost per unit and increases his direct holdings to 81,385 shares. The RSUs vest on the earlier of one year from the grant date or the next annual stockholder meeting, as long as he continues serving the company.
Lumexa Imaging Holdings, Inc. reported results of its 2026 Annual Meeting of Stockholders. Stockholders elected three Class I directors—Lee Cooper, Brian Regan and Caitlin Zulla—to serve until the 2029 annual meeting.
As of the April 13, 2026 record date, 96,110,039 common shares were entitled to vote. Lee Cooper received 87,523,628 votes for and 3,328,050 withheld, Brian Regan received 80,044,532 for and 10,807,146 withheld, and Caitlin Zulla received 87,156,663 for and 3,695,015 withheld, with 826,898 broker non-votes for each. Stockholders also ratified PricewaterhouseCoopers LLP as independent registered public accounting firm for the year ending December 31, 2026 with 91,555,829 votes for, 66,858 against and 55,889 abstentions.
Lumexa Imaging Holdings director Brett Brodnax reported an open-market purchase of 35,000 shares of Common Stock at $7.25 per share. Following this transaction, he directly owns 62,027 Lumexa Imaging Holdings shares, according to the Form 4 insider filing.